We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Images Identified for Breast Cancer Cell Histopathology

By LabMedica International staff writers
Posted on 11 Nov 2016
Breast cancer is the most prevalent form of cancer for women worldwide. More...
Current breast cancer clinical practice and treatment mainly relies on the evaluation of the disease's prognosis using the Bloom-Richardson grading system.

The advent of digital pathology and fast digital slide scanners has opened the possibility of automating the prognosis by applying image-processing methods and while this undoubtedly represents progress, image-processing methods have struggled to analyze high-grade breast cancer cells as these cells are often clustered together and have vague boundaries, which make successful detection extremely challenging.

An international team comprising engineers, mathematicians and doctors led by those at Trinity College Dublin (Ireland) have has applied a technique used for detecting damage in underwater marine structures to identify cancerous cells in breast cancer histopathology images. The team has proposed a novel segmentation algorithm for detecting individual nuclei from hematoxylin and eosin (H&E) stained breast histopathology images. This detection framework estimates a nuclei saliency map using tensor voting followed by boundary extraction of the nuclei on the saliency map using a Loopy Back Propagation (LBP) algorithm on a Markov Random Field (MRF).

The method was tested on both whole-slide images and frames of breast cancer histopathology images. The investigators considered the likelihood of every point in a histopathology image either being near a cell center or a cell boundary and using a belief propagation algorithm, the most suitable cell boundaries were then traced out. Test results show that the proposed method is suitable for nuclei segmentation in high-grade breast cancer histopathology images containing scenes depicting grade 3 nuclear pleomorphism (cancerous nuclei with marked variations from normal nuclei) even though these are quite challenging for traditional segmentation methods to detect.

Maqlin Paramanandam, PhD, the lead author of the study said, “The potential for this technology is very exciting and we are delighted that this international and inter-disciplinary team has worked so well at tackling a real bottle-neck in automating the diagnosis of breast cancer using histopathology images.” The study was published on September 20, 2016, in the journal Public Library of Science ONE.

Related Links:
Trinity College Dublin


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.